- Home
- Publications
- Publication Search
- Publication Details
Title
Immune checkpoint receptors: homeostatic regulators of immunity
Authors
Keywords
Checkpoint, Immunotherapy, ALD
Journal
Hepatology International
Volume 12, Issue 3, Pages 223-236
Publisher
Springer Nature
Online
2018-05-08
DOI
10.1007/s12072-018-9867-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1 pathway and its clinical application: A 20 year journey after discovery of the complete human PD - 1 gene
- (2018) Kristin Nicole Berger et al. GENE
- Soluble Tim-3 and Gal-9 are associated with renal allograft dysfunction in kidney transplant recipients: A cross-sectional study
- (2018) Ya Mei Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The TIM3-Gal9 immune checkpoint axis is inter-linked with severity of Alcoholic Liver Disease
- (2018) A. Riva et al. JOURNAL OF HEPATOLOGY
- Antibodies to watch in 2018
- (2018) Hélène Kaplon et al. mAbs
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA
- (2017) Nikhil Vergis et al. GASTROENTEROLOGY
- MAIT cells: a novel therapeutic target for alcoholic liver disease?
- (2017) Bin Gao et al. GUT
- Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease
- (2017) Antonio Riva et al. GUT
- Targeting Immune Cell Checkpoints during Sepsis
- (2017) Naeem Patil et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Control of NK Cell Activation by Immune Checkpoint Molecules
- (2017) Asma Beldi-Ferchiou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination
- (2017) Arash Memarnejadian et al. JOURNAL OF IMMUNOLOGY
- Melanoma subtypes demonstrate distinct PD-L1 expression profiles
- (2017) Genevieve J Kaunitz et al. LABORATORY INVESTIGATION
- New metrics for the Lancet Standing Commission on Liver Disease in the UK
- (2017) Roger Williams et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Noninvasive detection of acute renal allograft rejection by measurement of soluble Tim-3 in urine
- (2017) Dajin Chen et al. Molecular Medicine Reports
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
- (2017) Xinxin Zhu et al. Oncotarget
- Modulation of Tim-3 Expression by Antigen-Dependent and -Independent Factors on T Cells from Patients with Chronic Hepatitis B Virus Infection
- (2017) Jie Dong et al. Frontiers in Cellular and Infection Microbiology
- Soluble CD80 Protein Delays Tumor Growth and Promotes Tumor-Infiltrating Lymphocytes
- (2017) Lucas A. Horn et al. Cancer Immunology Research
- Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
- (2017) Abhishek D. Garg et al. OncoImmunology
- Trial watch: Immune checkpoint blockers for cancer therapy
- (2017) Claire Vanpouille-Box et al. OncoImmunology
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis
- (2016) Sara Gandini et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The challenges of multi-drug-resistance in hepatology
- (2016) Javier Fernández et al. JOURNAL OF HEPATOLOGY
- Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1
- (2016) Andriani C. Patera et al. JOURNAL OF LEUKOCYTE BIOLOGY
- PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas
- (2016) Aaron Goodman et al. Nature Reviews Clinical Oncology
- Role of Tim-3 in hepatitis B virus infection: An overview
- (2016) Yuan Liu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Review paper Current views on the mechanisms of immune responses to trauma and infection
- (2015) Aneta Małgorzata Binkowska et al. Central European Journal of Immunology
- Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
- (2015) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Blockade of PD1 and TIM3 Restores Innate and Adaptive Immunity in Patients With Acute Alcoholic Hepatitis
- (2015) Lee J.L. Markwick et al. GASTROENTEROLOGY
- Identifying Molecular Targets to Improve Immune Function in Alcoholic Hepatitis
- (2015) Ramon Bataller et al. GASTROENTEROLOGY
- Alcoholic liver disease: mechanisms of injury and targeted treatment
- (2015) Alexandre Louvet et al. Nature Reviews Gastroenterology & Hepatology
- Prednisolone or Pentoxifylline for Alcoholic Hepatitis
- (2015) Mark R. Thursz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma soluble Tim-3 emerges as an inhibitor in sepsis: sepsis contrary to membrane Tim-3 on monocytes
- (2015) F. Ren et al. TISSUE ANTIGENS
- T cell exhaustion during persistent viral infections
- (2015) Shannon M. Kahan et al. VIROLOGY
- EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease
- (2015) JOURNAL OF HEPATOLOGY
- Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
- (2014) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
- (2014) Rajiv Jalan et al. JOURNAL OF HEPATOLOGY
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
- (2014) Caroline Robert et al. LANCET
- Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
- (2014) Roger Williams et al. LANCET
- Immune dysfunction in cirrhosis
- (2014) Nora Sipeki WORLD JOURNAL OF GASTROENTEROLOGY
- B-cell exhaustion in HIV infection
- (2014) Susan Moir et al. Current Opinion in HIV and AIDS
- The Soluble Form of CTLA-4 from Serum of Patients with Autoimmune Diseases Regulates T-Cell Responses
- (2014) Rita Simone et al. Biomed Research International
- A Soluble Form of CD80 Enhances Antitumor Immunity by Neutralizing Programmed Death Ligand-1 and Simultaneously Providing Costimulation
- (2014) S. T. Haile et al. Cancer Immunology Research
- Recurrent severe alcoholic hepatitis
- (2013) Jonathan R. Potts et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- PD-L1 Blockade Attenuated Sepsis-Induced Liver Injury in a Mouse Cecal Ligation and Puncture Model
- (2013) Weimin Zhu et al. MEDIATORS OF INFLAMMATION
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- The changing immune system in sepsis
- (2013) Jonathan S Boomer et al. Virulence
- Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than “Exhaustion” of Human CD8 T Cells
- (2013) Amandine Legat et al. Frontiers in Immunology
- The Tim3-Galectin 9 Pathway Induces Antibacterial Activity in Human Macrophages Infected with Mycobacterium tuberculosis
- (2012) I. Sada-Ovalle et al. JOURNAL OF IMMUNOLOGY
- Antigen-Independent Induction of Tim-3 Expression on Human T Cells by the Common -Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Is Associated with Proliferation and Is Dependent on the Phosphoinositide 3-Kinase Pathway
- (2012) S. Mujib et al. JOURNAL OF IMMUNOLOGY
- Persistent inflammation and immunosuppression
- (2012) Lori F. Gentile et al. Journal of Trauma and Acute Care Surgery
- B-Lymphocyte Dysfunction in Chronic HIV-1 Infection Does Not Prevent Cross-Clade Neutralization Breadth
- (2012) S. Boliar et al. JOURNAL OF VIROLOGY
- Sepsis studies need new direction
- (2012) Jonathan Cohen et al. LANCET INFECTIOUS DISEASES
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization
- (2012) Lukas Baitsch et al. PLoS One
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Tim-3-Expressing CD4+ and CD8+ T Cells in Human Tuberculosis (TB) Exhibit Polarized Effector Memory Phenotypes and Stronger Anti-TB Effector Functions
- (2012) Yueqin Qiu et al. PLoS Pathogens
- The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
- (2012) Phillipp Hartmann et al. Frontiers in Physiology
- Dual biological effects of the cytokines interleukin-10 and interferon-γ
- (2011) Cailin Moira Wilke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Anti-TIM3 Antibody Promotes T Cell IFN- -Mediated Antitumor Immunity and Suppresses Established Tumors
- (2011) S. F. Ngiow et al. CANCER RESEARCH
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Immune Dysfunction and Infections in Patients With Cirrhosis
- (2011) Alexander R. Bonnel et al. Clinical Gastroenterology and Hepatology
- B7-H2 Is a Costimulatory Ligand for CD28 in Human
- (2011) Sheng Yao et al. IMMUNITY
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
- (2011) Jonathan S. Boomer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Search for Effective Therapy for Sepsis
- (2011) Derek C. Angus JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis
- (2011) Xinjing Wang et al. JOURNAL OF INFECTION
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
- (2011) O. S. Qureshi et al. SCIENCE
- Emerging Tim-3 functions in antimicrobial and tumor immunity
- (2011) Kaori Sakuishi et al. TRENDS IN IMMUNOLOGY
- B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
- (2010) J.-J. Park et al. BLOOD
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B
- (2010) Ji Chen et al. INFLAMMATION RESEARCH
- Tim3 binding to galectin-9 stimulates antimicrobial immunity
- (2010) Pushpa Jayaraman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Editorial: PD-1, a new target for sepsis treatment: better late than never
- (2010) S. M. Goyert et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis
- (2010) P. Brahmamdam et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The 6-month abstinence rule in liver transplantation
- (2010) Debbie L Shawcross et al. LANCET
- Programmed death-1–induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection
- (2010) Elias A Said et al. NATURE MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
- (2010) H.-T. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines
- (2009) William D. Hastings et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Systemic inflammatory response following acute traumatic brain injury
- (2009) Jia Lu Frontiers in Bioscience-Landmark
- Infection in Patients With Severe Alcoholic Hepatitis Treated With Steroids: Early Response to Therapy Is the Key Factor
- (2009) Alexandre Louvet et al. GASTROENTEROLOGY
- Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
- (2009) J. F. Grosso et al. JOURNAL OF IMMUNOLOGY
- Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells
- (2009) L. Golden-Mason et al. JOURNAL OF VIROLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
- (2008) T. Azuma et al. BLOOD
- The Compensatory Anti-inflammatory Response Syndrome (CARS) in Critically Ill Patients
- (2008) Nicholas S. Ward et al. CLINICS IN CHEST MEDICINE
- Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion
- (2008) Alexander Evans et al. HEPATOLOGY
- Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
- (2008) R. Brad Jones et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
- (2008) Shawn D Blackburn et al. NATURE IMMUNOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
- (2008) M. Marzec et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Compensatory anti-inflammatory response syndrome
- (2008) Jean-Marc Cavaillon et al. THROMBOSIS AND HAEMOSTASIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now